FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Histreline Acetate Implant
Status: Currently in Shortage
»Date first posted: 02/11/2021
»Therapeutic Categories: Oncology

Endo Pharmaceuticals, Inc. (New 02/11/2021)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Vantas 50 mg Implantation Kit (NDC 67979-500-01) Unavailable. Estimated Shortage Duration TBD Requirements related to complying with good manufacturing practices

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English